Viswanathan Ravi
Insider CIK 1479386 · ILIU 10% owner · CVT 10% owner · PHAS 10% owner · GLYC 10% owner · AKAO 10% owner · AVEO 10% owner · WDAY 10% owner · MM 10% owner · HIVE 10% owner · BOX 10% owner · MULE 10% owner · TCON 10% owner · CASC 10% owner · CRCM 10% owner · ARDX 10% owner · APPN 10% owner · MRSN 10% owner · CLVS 10% owner · ROKA 10% owner · OMTH Director, 10% owner · RARX 10% owner · TSRO 10% owner · MIRN 10% owner · CERC 10% owner · DERM 10% owner · DUOL 10% owner · EPZM 10% owner · LOXO 10% owner · ADAP 10% owner · RYTM 10% owner · ESTC 10% owner · SURF 10% owner · ABIO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DUOL Duolingo, Inc. | J Other | 2022-07-08 | 2022-07-12 | 11,466 | — | $0 | 11,466 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-07-08 | 2022-07-12 | 11,466 | — | $0 | 0 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-07-08 | 2022-07-12 | 2,200 | — | $0 | 6,587 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-07-08 | 2022-07-12 | 1,000,000 | — | $0 | 2,239,835 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-06-24 | 2022-06-28 | 5,733 | — | $0 | 5,733 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-06-24 | 2022-06-28 | 1,097 | — | $0 | 4,387 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-06-24 | 2022-06-28 | 5,733 | — | $0 | 0 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-06-24 | 2022-06-28 | 500,000 | — | $0 | 3,239,835 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-03-24 | 2022-03-25 | 11,467 | — | $0 | 11,467 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-03-24 | 2022-03-25 | 11,467 | — | $0 | 0 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-03-24 | 2022-03-25 | 2,194 | — | $0 | 3,290 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-03-24 | 2022-03-25 | 1,000,000 | — | $0 | 3,739,835 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-02-15 | 2022-02-16 | 5,732 | — | $0 | 5,732 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-02-15 | 2022-02-16 | 5,732 | — | $0 | 0 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-02-15 | 2022-02-16 | 1,096 | — | $0 | 1,096 | SEC↗ |
| DUOL Duolingo, Inc. | J Other | 2022-02-15 | 2022-02-16 | 500,000 | — | $0 | 4,739,835 | SEC↗ |
| DUOL Duolingo, Inc. | C Conversion deriv | 2022-02-09 | 2022-02-16 | 5,239,835 | — | $0 | 0 | SEC↗ |
| DUOL Duolingo, Inc. | C Conversion | 2022-02-09 | 2022-02-16 | 5,239,835 | — | $0 | 5,239,835 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,177 | $5.00 | $5.9K | 3,279,627 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,279,627 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 181,190 | $0.12 | $21.7K | 442,055 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 4,349 | $5.00 | $21.7K | 437,706 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 437,706 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | $0.12 | $5.9K | 3,280,804 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 49,030 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,124,301 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 1,800,000 | $5.00 | $9.00M | 6,641,634 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,841,634 | — | $0 | 4,841,634 | SEC↗ |
| ESTC Elastic N.V. | C Conversion deriv | 2018-10-10 | 2018-10-10 | 4,155,995 | — | $0 | 0 | SEC↗ |
| ESTC Elastic N.V. | C Conversion deriv | 2018-10-10 | 2018-10-10 | 1,528,117 | — | $0 | 0 | SEC↗ |
| ESTC Elastic N.V. | C Conversion | 2018-10-10 | 2018-10-10 | 1,528,117 | — | $0 | 1,528,117 | SEC↗ |
| ESTC Elastic N.V. | C Conversion | 2018-10-10 | 2018-10-10 | 4,155,995 | — | $0 | 4,155,995 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 12,000,000 | $1.67 | $20.04M | 12,000,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 3,000,000 | $1.67 | $5.01M | 82,978,668 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-08-21 | 2018-08-22 | 663,716 | $2.26 | $1.50M | 18,698,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-19 | 2018-07-20 | 50,600 | $2.00 | $101.2K | 18,034,322 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-18 | 2018-07-20 | 200,000 | $1.95 | $390.0K | 17,983,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-28 | 2018-06-28 | 187,130 | $2.10 | $393.0K | 17,783,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-27 | 2018-06-28 | 5,295 | $2.15 | $11.4K | 17,596,592 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-30 | 2018-05-30 | 275 | $2.15 | $591 | 17,591,297 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,667 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,666 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-21 | 2018-05-21 | 32,200 | $2.14 | $68.9K | 17,591,022 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-18 | 2018-05-21 | 20,100 | $2.14 | $43.0K | 17,558,822 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-17 | 2018-05-21 | 184,179 | $2.13 | $392.3K | 17,538,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-08 | 2018-05-10 | 70,873 | $2.13 | $151.0K | 17,354,543 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 2,576,939 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 2,576,939 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 858,978 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 858,978 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 6,995,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 133,333 | $15.00 | $2.00M | 3,312,877 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,179,544 | — | $0 | 3,179,544 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-10 | 2018-04-10 | 203,200 | $2.46 | $499.9K | 17,283,670 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-09 | 2018-04-10 | 32,100 | $2.43 | $78.0K | 17,080,470 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-06 | 2018-04-10 | 685,676 | $2.24 | $1.54M | 17,048,370 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-27 | 2018-03-28 | 6,000,000 | $1.92 | $11.52M | 79,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-26 | 2018-03-28 | 571,164 | $1.90 | $1.09M | 73,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-23 | 2018-03-23 | 294,090 | $1.95 | $573.5K | 73,407,508 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-22 | 2018-03-23 | 869,574 | $1.90 | $1.65M | 73,113,418 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-21 | 2018-03-23 | 104,844 | $1.81 | $189.8K | 72,243,844 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 10,882,574 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-06 | 2018-03-06 | 3,159 | $59.82 | $189.0K | 739,516 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-06 | 2018-03-06 | 12,634 | $59.82 | $755.8K | 9,681,129 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 4,311 | $59.76 | $257.6K | 736,357 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 400 | $59.15 | $23.7K | 732,046 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 7,557 | $58.28 | $440.4K | 731,646 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 17,248 | $59.76 | $1.03M | 9,668,495 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 1,600 | $59.15 | $94.6K | 9,651,247 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-05 | 2018-03-06 | 30,321 | $58.28 | $1.77M | 9,649,647 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 4,465 | $57.34 | $256.0K | 724,089 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 1,020 | $56.66 | $57.8K | 719,624 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 1,600 | $55.01 | $88.0K | 718,604 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 6,575 | $54.32 | $357.2K | 717,004 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 17,859 | $57.34 | $1.02M | 9,619,326 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 4,080 | $56.66 | $231.2K | 9,601,467 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 6,399 | $55.01 | $352.0K | 9,597,387 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2018-03-02 | 2018-03-06 | 26,304 | $54.32 | $1.43M | 9,590,988 | SEC↗ |
| ABIO ARCA biopharma, Inc. | S Sale | 2018-02-26 | 2018-02-27 | 1,460,209 | $0.50 | $730.1K | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | C Conversion deriv | 2018-02-20 | 2018-02-22 | 1,818,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | C Conversion | 2018-02-20 | 2018-02-22 | 1,818,000 | $3.30 | $6.00M | 10,882,574 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2018-02-16 | 2018-02-21 | 2,000,000 | $6.00 | $12.00M | 5,490,073 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 13,621 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 13,621 | — | $0 | 13,621 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 27,242 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 509 | — | $0 | 509 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 1,014 | — | $0 | 1,014 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 2,724,202 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2018-01-26 | 2018-01-26 | 410,000 | $9.75 | $4.00M | 4,228,940 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 2,724,202 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-27 | 2017-11-27 | 569,620 | $19.49 | $11.10M | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 569,620 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 3,293,822 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 2,820,516 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-20 | 2017-11-21 | 2,820,516 | $19.49 | $54.97M | 0 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 336 | — | $0 | 336 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 10,000 | — | $0 | 0 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRCM Care.com Inc | J Other | 2017-11-06 | 2017-11-08 | 1,000,000 | — | $0 | 2,256,013 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,927,708 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 1,402,870 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 2,927,708 | — | $0 | 4,359,956 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 1,402,870 | — | $0 | 1,432,248 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 550,000 | $17.00 | $9.35M | 4,909,956 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2017-08-28 | 2017-08-30 | 3,394,439 | — | $0 | 3,818,940 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 18,001,419 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 11,931,173 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 2,216,626 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2017-07-03 | 2017-07-06 | 1,000,000 | $15.00 | $15.00M | 8,140,138 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion | 2017-07-03 | 2017-07-06 | 7,140,138 | — | $0 | 7,140,138 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 6,114,338 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2017-03-28 | 2017-03-29 | 6,000,000 | $0.50 | $3.00M | 16,362,694 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2017-03-27 | 2017-03-28 | 12,870,000 | $0.70 | $9.01M | 72,139,000 | SEC↗ |
| MULE MULESOFT, INC | J Other deriv | 2017-03-22 | 2017-03-22 | 2,576,939 | — | $0 | 2,576,939 | SEC↗ |
| MULE MULESOFT, INC | J Other deriv | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 227,125 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 631,853 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 681,377 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 1,895,562 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 605,668 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 2,064,048 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 8,000,038 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 1,689,436 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | J Other deriv | 2017-03-22 | 2017-03-22 | 858,978 | — | $0 | 858,978 | SEC↗ |
| MULE MULESOFT, INC | J Other | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2017-03-22 | 2017-03-22 | 2,576,939 | — | $0 | 2,576,939 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2017-03-22 | 2017-03-22 | 12,359,190 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | J Other | 2017-03-22 | 2017-03-22 | 2,576,939 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | J Other | 2017-03-22 | 2017-03-22 | 858,978 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2017-03-22 | 2017-03-22 | 858,978 | — | $0 | 858,978 | SEC↗ |
| AKAO Achaogen Inc | P Buy | 2016-12-19 | 2016-12-19 | 500,000 | $13.50 | $6.75M | 5,215,128 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2016-11-29 | 2016-11-29 | 869,565 | $5.75 | $5.00M | 2,758,039 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 4,362,472 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise deriv | 2016-10-31 | 2016-10-31 | 80,658 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 12,447,605 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 4,689,657 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 669,951 | — | $0 | 2,528,401 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 1,778,227 | — | $0 | 1,858,450 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2016-10-31 | 2016-10-31 | 435 | $13.00 | $5.7K | 80,223 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise | 2016-10-31 | 2016-10-31 | 80,658 | $0.07 | $5.6K | 80,658 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 338,462 | $13.00 | $4.40M | 3,490,073 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 623,210 | — | $0 | 3,151,611 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 5,714,286 | — | $0 | 5,714,286 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-30 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2016-07-29 | 2016-08-02 | 20,120,724 | — | $0 | 20,120,724 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2016-07-29 | 2016-08-02 | 20,120,724 | $0.10 | $2.01M | 55,418,811 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-07-18 | 2016-07-20 | 763,650 | $8.73 | $6.67M | 2,665,519 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-07-18 | 2016-07-20 | 763,651 | $8.73 | $6.67M | 2,665,520 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2016-03-18 | 2016-03-18 | 710,429 | $35.19 | $25.00M | 710,429 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2016-03-18 | 2016-03-18 | 710,429 | $35.19 | $25.00M | 9,564,684 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-01-13 | 2016-01-14 | 500,000 | $10.00 | $5.00M | 1,901,869 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-01-13 | 2016-01-14 | 500,000 | $10.00 | $5.00M | 1,901,869 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 1,111,111 | $9.00 | $10.00M | 5,854,351 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2015-10-20 | 2015-10-20 | 16,638,880 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2015-10-20 | 2015-10-20 | 594,245 | — | $0 | 594,245 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,971,517 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 31,650 | — | $0 | 2,114,375 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 257,516 | — | $0 | 1,499,166 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,241,650 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 2,082,725 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,241,650 | — | $0 | 1,241,650 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2015-06-15 | 2015-06-15 | 553 | $54.96 | $30.4K | 0 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2015-06-12 | 2015-06-15 | 336 | $54.53 | $18.3K | 553 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 1,000,000 | — | $0 | 8,854,255 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-06-01 | 2015-06-02 | 336 | — | $0 | 889 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion deriv | 2015-02-04 | 2015-02-05 | 5,373,396 | — | $0 | 0 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion | 2015-02-04 | 2015-02-05 | 1,388,474 | — | $0 | 1,388,474 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2015-02-04 | 2015-02-05 | 500,000 | $10.00 | $5.00M | 1,888,474 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-29 | 1,653,761 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion deriv | 2015-01-28 | 2015-01-29 | 274,916 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | J Other deriv | 2015-01-28 | 2015-01-29 | 2,091,457 | — | $0 | 2,091,457 | SEC↗ |
| BOX BOX INC | J Other | 2015-01-28 | 2015-01-29 | 2,091,457 | — | $0 | 0 | SEC↗ |
| BOX BOX INC | C Conversion | 2015-01-28 | 2015-01-29 | 1,928,677 | — | $0 | 2,091,457 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2014-12-23 | 2014-12-29 | 19,868,965 | — | $0 | 19,868,965 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2014-12-23 | 2014-12-29 | 19,868,965 | $0.10 | $1.99M | 35,298,087 | SEC↗ |
| CVT CVENT INC | J Other | 2014-11-25 | 2014-11-28 | 336 | — | $0 | 336 | SEC↗ |
| CVT CVENT INC | J Other | 2014-11-25 | 2014-11-28 | 10,000 | — | $0 | 0 | SEC↗ |
| CVT CVENT INC | J Other | 2014-11-25 | 2014-11-28 | 1,000,000 | — | $0 | 3,994,106 | SEC↗ |
| CVT CVENT INC | J Other | 2014-11-25 | 2014-11-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 2,378,408 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 382,840 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 655,321 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2014-10-08 | 2014-10-08 | 69,112 | $16.00 | $1.11M | 3,502,922 | SEC↗ |
| DERM Dermira, Inc. | C Conversion | 2014-10-08 | 2014-10-08 | 3,416,569 | — | $0 | 3,433,810 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-18 | 2014-08-18 | 433 | $35.56 | $15.4K | 0 | SEC↗ |
| CVT CVENT INC | S Sale | 2014-08-18 | 2014-08-18 | 336 | $26.04 | $8.7K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2014-08-14 | 2014-08-18 | 12,900 | — | $0 | 12,900 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2014-08-14 | 2014-08-18 | 12,900 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2014-08-14 | 2014-08-18 | 433 | — | $0 | 433 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2014-08-14 | 2014-08-18 | 1,290,000 | — | $0 | 4,743,240 | SEC↗ |
| CVT CVENT INC | J Other | 2014-08-14 | 2014-08-18 | 336 | — | $0 | 336 | SEC↗ |
| CVT CVENT INC | J Other | 2014-08-14 | 2014-08-18 | 10,000 | — | $0 | 0 | SEC↗ |
| CVT CVENT INC | J Other | 2014-08-14 | 2014-08-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CVT CVENT INC | J Other | 2014-08-14 | 2014-08-18 | 1,000,000 | — | $0 | 4,994,106 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 1,558,651 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 230,769 | $13.00 | $3.00M | 1,789,420 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 1,558,651 | — | $0 | 1,558,651 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-22 | 5,987,892 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-22 | 8,555,784 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-22 | 4,030,224 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-22 | 12,360,000 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy | 2014-07-22 | 2014-07-22 | 383,333 | $12.00 | $4.60M | 3,216,810 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-22 | 1,119,565 | — | $0 | 1,124,299 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-22 | 365,056 | — | $0 | 1,489,355 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-22 | 801,741 | — | $0 | 2,291,096 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-22 | 542,381 | — | $0 | 2,833,477 | SEC↗ |
| HIVE AEROHIVE NETWORKS, INC | C Conversion deriv | 2014-04-02 | 2014-04-03 | 3,588,446 | — | $0 | 0 | SEC↗ |
| HIVE AEROHIVE NETWORKS, INC | C Conversion deriv | 2014-04-02 | 2014-04-03 | 1,065,143 | — | $0 | 0 | SEC↗ |
| HIVE AEROHIVE NETWORKS, INC | C Conversion | 2014-04-02 | 2014-04-03 | 4,653,589 | — | $0 | 4,673,589 | SEC↗ |
| CRCM Care.com Inc | C Conversion deriv | 2014-01-29 | 2014-01-29 | 401,837 | — | $0 | 0 | SEC↗ |
| CRCM Care.com Inc | C Conversion deriv | 2014-01-29 | 2014-01-29 | 612,089 | — | $0 | 0 | SEC↗ |
| CRCM Care.com Inc | C Conversion deriv | 2014-01-29 | 2014-01-29 | 2,242,087 | — | $0 | 0 | SEC↗ |
| CRCM Care.com Inc | C Conversion | 2014-01-29 | 2014-01-29 | 612,089 | — | $0 | 3,256,013 | SEC↗ |
| CRCM Care.com Inc | C Conversion | 2014-01-29 | 2014-01-29 | 401,837 | — | $0 | 2,643,924 | SEC↗ |
| CRCM Care.com Inc | C Conversion | 2014-01-29 | 2014-01-29 | 2,242,087 | — | $0 | 2,242,087 | SEC↗ |
| CVT CVENT INC | S Sale | 2014-01-21 | 2014-01-23 | 169,887 | $35.50 | $6.03M | 5,994,106 | SEC↗ |
| CVT CVENT INC | S Sale | 2014-01-16 | 2014-01-21 | 1,132,589 | $35.50 | $40.21M | 6,163,993 | SEC↗ |
| GLYC GLYCOMIMETICS INC | C Conversion deriv | 2014-01-15 | 2014-01-15 | 11,824,058 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | C Conversion | 2014-01-15 | 2014-01-15 | 3,580,877 | — | $0 | 3,580,877 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2014-01-15 | 2014-01-15 | 512,500 | $8.00 | $4.10M | 4,093,377 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-11-15 | 2013-11-18 | 23,700 | $20.31 | $481.3K | 380,700 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-11-15 | 2013-11-18 | 25,800 | $19.31 | $498.2K | 406,500 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-11-14 | 2013-11-18 | 40,921 | $20.91 | $855.7K | 40,921 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-11-14 | 2013-11-18 | 152,459 | $19.99 | $3.05M | 193,380 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-11-14 | 2013-11-18 | 163,620 | $19.04 | $3.12M | 357,000 | SEC↗ |
| CVT CVENT INC | C Conversion deriv | 2013-08-14 | 2013-08-14 | 7,296,582 | — | $0 | 0 | SEC↗ |
| CVT CVENT INC | C Conversion | 2013-08-14 | 2013-08-14 | 7,296,582 | — | $0 | 7,296,582 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | D To issuer | 2013-07-18 | 2013-07-18 | 5,833,213 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 16,899,721 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 5,633,240 | — | $0 | 5,633,240 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-07 | 400,000 | $15.00 | $6.00M | 6,033,240 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-06-04 | 2013-06-05 | 16,450 | — | $0 | 16,450 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-06-04 | 2013-06-05 | 16,450 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-06-04 | 2013-06-05 | 553 | — | $0 | 553 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-06-04 | 2013-06-05 | 1,645,000 | — | $0 | 9,854,255 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 1,139,890 | — | $0 | 2,279,781 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 11,399 | — | $0 | 11,399 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 11,399 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 383 | — | $0 | 383 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion deriv | 2013-04-16 | 2013-04-17 | 633,219 | — | $0 | 0 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion deriv | 2013-04-16 | 2013-04-17 | 156,250 | — | $0 | 0 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion deriv | 2013-04-16 | 2013-04-17 | 6,165,747 | — | $0 | 0 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | P Buy | 2013-04-16 | 2013-04-17 | 625,000 | $8.00 | $5.00M | 5,833,213 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion | 2013-04-16 | 2013-04-17 | 4,418,940 | — | $0 | 5,208,213 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion | 2013-04-16 | 2013-04-17 | 633,219 | $8.00 | $5.07M | 789,273 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | S Sale | 2013-04-16 | 2013-04-17 | 196 | $8.00 | $1.6K | 156,054 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | C Conversion | 2013-04-16 | 2013-04-17 | 156,250 | $0.01 | $1.6K | 156,250 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | A Award deriv | 2013-04-11 | 2013-04-11 | 156,250 | — | $0 | 156,250 | SEC↗ |
| OMTH Omthera Pharmaceuticals, I | A Award deriv | 2013-04-11 | 2013-04-11 | 633,219 | — | $0 | 633,219 | SEC↗ |
| WDAY Workday, Inc. | C Conversion deriv | 2013-04-09 | 2013-04-11 | 2,321,212 | — | $0 | 4,642,425 | SEC↗ |
| WDAY Workday, Inc. | C Conversion | 2013-04-09 | 2013-04-11 | 2,321,212 | — | $0 | 2,321,212 | SEC↗ |
| WDAY Workday, Inc. | J Other | 2013-04-09 | 2013-04-11 | 23,212 | — | $0 | 23,212 | SEC↗ |
| WDAY Workday, Inc. | J Other | 2013-04-09 | 2013-04-11 | 2,321,212 | — | $0 | 0 | SEC↗ |
| WDAY Workday, Inc. | J Other | 2013-04-09 | 2013-04-11 | 781 | — | $0 | 781 | SEC↗ |
| WDAY Workday, Inc. | J Other | 2013-04-09 | 2013-04-11 | 23,212 | — | $0 | 0 | SEC↗ |
| MM Millennial Media Inc. | S Sale | 2012-10-29 | 2012-10-30 | 1,597,787 | $13.44 | $21.47M | 8,196,614 | SEC↗ |
| WDAY Workday, Inc. | C Conversion deriv | 2012-10-17 | 2012-10-18 | 6,963,637 | — | $0 | 0 | SEC↗ |
| WDAY Workday, Inc. | C Conversion deriv | 2012-10-17 | 2012-10-18 | 6,963,637 | — | $0 | 6,963,637 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion deriv | 2012-07-03 | 2012-07-03 | 5,134,285 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion deriv | 2012-07-03 | 2012-07-03 | 5,253,859 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2012-07-03 | 2012-07-03 | 1,111,111 | $13.50 | $15.00M | 11,499,255 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion | 2012-07-03 | 2012-07-03 | 10,388,144 | — | $0 | 10,388,144 | SEC↗ |
| MM Millennial Media Inc. | C Conversion deriv | 2012-04-03 | 2012-04-04 | 8,036,099 | — | $0 | 0 | SEC↗ |
| MM Millennial Media Inc. | C Conversion deriv | 2012-04-03 | 2012-04-04 | 1,758,302 | — | $0 | 0 | SEC↗ |
| MM Millennial Media Inc. | C Conversion | 2012-04-03 | 2012-04-04 | 9,794,401 | — | $0 | 9,794,401 | SEC↗ |